Morgan Stanley Endra Life Sciences Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.23 - $319.0 $3,220 - $4.47 Million
14,000 Added 1.65%
864,573 $265,000
Q1 2022

May 13, 2022
BUY
$0.36 - $0.77 $2,519 - $5,389
6,999 Added 0.83%
850,573 $332,000
Q4 2021

Feb 14, 2022
BUY
$0.69 - $1.73 $421,770 - $1.06 Million
611,262 Added 263.12%
843,574 $583,000
Q3 2021

Nov 15, 2021
BUY
$1.38 - $2.15 $320,590 - $499,470
232,312 New
232,312 $402,000

About ENDRA Life Sciences Inc.

NDRA Quotes by TradingView
  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $382M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email